Returning to the observation that CD4+ T cells from MS patients showed DNA hypomethylation and inappropriate HLA-DRB1 expression [29,46], it is of paramount importance that the promoter region of the European-derived DRB1*1501 allele reportedly harbors a VDRE [43]. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.